Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Rxi Pharmaceuticals Corp (NASDAQ:RXII)

0.649
Delayed Data
As of 3:58pm ET
 -0.001 / -0.15%
Today’s Change
0.60
Today|||52-Week Range
3.27
-9.19%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues399.0K71.0K34.0K19.0K
 
 
 
 
 
Depreciation And Amortization99.0K87.0K77.0K53.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses21.2M8.8M10.2M9.0M
 
 
 
 
 
Research And Development17.7M5.7M6.9M5.4M
 
 
 
 
 
Total Operating Expenses21.3M8.9M10.3M9.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-20.9M-8.8M-10.2M-9.0M
 
 
 
 
 
Other Expenses0.009.0K-2.0K6.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-20.9M-8.8M-10.2M-9.0M
 
 
 
 
 
Preferred Dividend-8.6M-4.1M-209.0K-2.1M
 
 
 
 
 
Net Income-20.9M-8.8M-10.2M-9.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS1.0M1.6M5.0M6.7M
 
 
 
 
 
Shares To Calculate EPS Diluted1.0M1.6M5.0M6.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$28.80-$7.90-$2.10-$1.64
 
 
 
 
 
EPS Diluted-$28.80-$7.90-$2.10-$1.64